AW
ALXN

Alpha Windward’s Alexion Pharmaceuticals ALXN Stock Holding History

Alpha Windward’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-95
Closed -$11K – 400
2020
Q3 		$11K Sell
95
-52
-35% -$5.61K 0.01% 350
2020
Q2 		$16K Buy
+147
New +$15.6K 0.01% 343
2015
Q2 		– Sell
-350
Closed -$61K – 485
2015
Q1 		$61K Hold
350
– – 0.04% 298
2014
Q4 		$65K Buy
+350
New +$64.9K 0.04% 297

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Alpha Windward's ALXN Position: Q4 2020 in Review

Alpha Windward sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 95 shares — an estimated $11K sold.

Alpha Windward first reported a position in ALXN in Q4 2014 and held it in 4 quarters. The position peaked at $65K in Q4 2014. 824 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

  • Alpha Windward reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Alpha Windward sold 95 Alexion Pharmaceuticals shares in Q4 2020, an estimated $11K.
  • Alpha Windward first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Alpha Windward's Alexion Pharmaceuticals position peaked at $65K in Q4 2014.
  • 824 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.